慢性阻塞性肺疾病合并高血糖强化血糖控制的医疗费用特征分析  

Features of the medical costs of intensive glucose control on acute exacerbation of chronic obstructive pulmonary disease with hyperglycemia

作　　者：高凌云[1] 杨恂[1] 杨建南[1] 

机构地区：[1]成都大学附属医院呼吸科,610081

出　　处：《重庆医学》2012年第2期122-123,126,共3页Chongqing medicine

基　　金：四川省卫生厅科研基金资助项目(070317)

摘　　要：目的研究强化血糖控制对慢性阻塞性肺疾病急性加重期(AECOPD)合并高血糖的费用的影响,为减轻患者负担提供理论依据和实践指导。方法采用同期、平行、随机对照试验的方法对研究对象的医疗费用进行分析。结果实验组西药费[(3 126.3±1794.1)元]与对照组[(4 115.5±2368.5)元]比较差异有统计学意义(P=0.004 2)。实验组总费用[(6 882.3±3 201.4)元]与对照组[(8 744.7±7 110.8)元]比较差异有统计学意义(P=0.040 4)。结论强化血糖控制利于降低患者的住院费用。Objective To study effects of costs of intensive glucose control on the acute exacerbation of chronic obstructive pulmonary disease with hyperglycemia to provide the theoretical basis and practical guidance for reduce the cost on patients.Methods Analyzed the costs of patients over the method of same period,parallel,randomized controlled trials.Results The medicine costs of experimental group（3 126.3±1 794.1） yuan were significantly different from the control group（4 115.5±2 368.5）yuan（P=0.004 2）.The total cost of the experimental group（6 882.3±3 201.4）yuan were significantly different from the control group（8 744.7±7 110.8）yuan（P=0.040 4）.Conclusion The methods of intensive glucose control helps reduce hospitalization costs.

关 键 词：肺疾病 慢性阻塞性 高血糖症 强化血糖控制 住院费用 

分 类 号：R563.9[医药卫生—呼吸系统]